Drug Development Needs “Clean-Slate Think” To Involve Patients All Along The Way – Pfizer’s Lewis-Hall
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug companies and other stakeholders should collaborate on developing a “clear framework” for patient engagement, Freda Lewis-Hall says at ISPOR.
You may also be interested in...
FDA Should Create “Clearly Articulated Pathway” For Patient-Centered Research – Pfizer’s Lewis-Hall
Pfizer CMO Freda Lewis-Hall acknowledged FDA’s current activities to promote patient-centered research, but called on the agency to lead in developing guidance to help industry be more proactive in incorporating patients into its research.
Social Media For Pharma: Focus On Building Community, Not Brands
Using social media as a marketing tool should be about building a community and not necessarily focused on brand marketing, Zoetis’ digital strategy manager tells conference attendees.
PCORI Building Non-Traditional Research Capacity With “Pipeline To Proposal” Awards
The Patient-Centered Outcomes Research Institute will make grants aimed at helping individuals and groups, including patients and their caregivers, build the capacity to submit research proposals to the institute.